Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. Its focused on the development of its novel therapeutic immunomodulating drug candidate, voclosporin, for the treatment of lupus nephritis.
| Website: | www.auriniapharma.com |
| Main Phone: | +1 250 708-4272 |
| Address: | 4464 Markham Street |
| Address 2: | Suite 1203 |
| State: | BC |
| City / Town: | Victoria |
| Country: | CAN |
| Postal Code: | V8Z 7X8 |
| Exchange: | TSX |
| Employees: | 16 |
| NAICS: | Pharmaceutical P |
| Last Price 7.03 | Change $ 0.10 | Change % 1.44 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 7.02 | High 7.03 | Low 6.94 | Prev Close 6.93 |
| Last Trade | Volume 400 | 52 Wk Hi 11.02 | 52 Wk Low 5.70 |
| Market Cap 590.9 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 84,051,758.00 | EPS (TTM) -1.20 | PE Ratio N/A | Exchange TSX |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 10.89 | 10.89 | 10.89 | 10.89 |
| Low Target Price Estimate | 10.89 | 10.89 | 10.89 | 10.89 |
| Mean Target Price Estimate | 10.89 | 10.89 | 10.89 | 10.89 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 03/29/16 | 03/29/16 | 03/29/16 | 03/29/16 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 0 | 0 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
